EUVIMEDEUVIMED entdecken
Crossref

Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment

Zhao Wang, Fenglin Miao, Lingwei Gu, Ruyi Zhang, Yuan Ma, Ying Li, Jialiang Zheng, Zhenhang Lin, Yilai Gao, Liyong Huang, Ye Shen, Ting Wu iD und 2 weitere

ACS Nano · 2024

DOI: 10.1021/acsnano.4c05657 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Zhao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine, Xiamen University, Xiamen 36…. Hauptthemen laut MEDLINE: Dendritic Cells, Fibrosarcoma, Doxorubicin, Nucleotides, Cyclic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China, Joint research center of School of Medicine, Xiamen University-Jiangsu Charity Biotech Co. Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsFibrosarcomaDoxorubicinNucleotides, CyclicNanoparticlesCancer VaccinesAnimalsMiceHumansMembrane ProteinsCell Line, TumorPolylactic Acid-Polyglycolic Acid CopolymerBiomimetic MaterialsMice, Inbred C57BLImmunotherapyCalreticulinNanovaccines

Stichwörter der Autor:innen

STING pathwaycalreticulinchemo-immunotherapydendritic cell nanovaccinefibrosarcoma

Substanzen

DoxorubicinNucleotides, CyclicCancer Vaccinescyclic guanosine monophosphate-adenosine monophosphateMembrane ProteinsPolylactic Acid-Polyglycolic Acid CopolymerCalreticulinNanovaccines

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Xiang'an Hospital of Xiamen University, Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, Fujian, China.
  • Cancer Research Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, Fujian, China.
  • Heji Hospital Affiliated with Changzhi Medical College, Changzhi 046000, Shanxi, China.
  • Fuzhou No. 1 Hospital Affiliated with Fujian Medical University, Fuzhou 350000, Fu Jian, China.
  • Shanghai Jiangxia Blood Technology Co., Ltd. Shanghai 200000, China.
  • Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, Fujian, China.

ORCID-Profile: Ting Wu, Fanghong Luo, Wengang Li

Förderung

  • Natural Science Foundation of Fujian Province
  • National Natural Science Foundation of China
  • Joint research center of School of Medicine, Xiamen University-Jiangsu Charity Biotech Co. Ltd
  • Joint laboratory of School of Medicine, Xiamen University-Shanghai Jiangxia Blood Technology Co. Ltd

Zitieren

APA

Wang, Z., Miao, F., Gu, L., Zhang, R., Ma, Y., Li, Y., Zheng, J., Lin, Z., Gao, Y., Huang, L., Shen, Y., Wu, T., Luo, F., & Li, W. (2024). Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. ACS Nano. https://doi.org/10.1021/acsnano.4c05657

Vancouver

Wang Z, Miao F, Gu L, Zhang R, Ma Y, Li Y, et al. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment. ACS Nano. 2024. doi:10.1021/acsnano.4c05657

BibTeX
@article{Wang2024,
  author = {Wang, Zhao and Miao, Fenglin and Gu, Lingwei and Zhang, Ruyi and Ma, Yuan and Li, Ying and Zheng, Jialiang and Lin, Zhenhang and Gao, Yilai and Huang, Liyong and Shen, Ye and Wu, Ting and Luo, Fanghong and Li, Wengang},
  title = {Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c05657}
}
Kostenlos starten →